Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04802356
Status:
RECRUITING
Last Update Posted:
2021-12-06
First Post:
2021-03-12
Brief Title:
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-12
First Submit QC Date:
March 12 2021
Study First Post Date:
2021-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-03
Last Update Post Date:
2021-12-06
Last Update Post Date Type:
ACTUAL